Simultaneous pancreas-kidney transplantation in HIV-infected patients: A case report and literature review

Transplantation Proceedings

Volumn 42, Issue 9, 2010, Pages 3887-3891

  Miro, J M ^a   Ricart, M J ^a   Trullas, J C ^b   Cofan, F ^a   Cervera, C ^a   Brunet, M ^a   Tuset, M ^a   Manzardo, C ^a   Oppenheimer, F ^a   Moreno, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF GIRONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMIKACIN; BASILIXIMAB; COLISTIN; GANCICLOVIR; HLA B57 ANTIGEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; OMEPRAZOLE; RANITIDINE; TACROLIMUS; TENOFOVIR;

ABDOMINAL ABSCESS; ADULT; ARTICLE; CASE REPORT; DIABETIC NEPHROPATHY; DONOR; GRAFT RECIPIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; LEUKOPENIA; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; ULCER; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FATAL OUTCOME; GRAFT REJECTION; GRAFT SURVIVAL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78649460284     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.003     Document Type: Article

References (23)

1. A. Mocroft, R. Brettle, and O. Kirk Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study AIDS 16 2002 1663
2. J.M. Miro, F. Aguero, and M. Laguno Liver transplantation in HIV/hepatitis co-infection J HIV Ther 12 2007 24
3. M.E. Roland, B. Barin, and L. Carlson HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes Am J Transplant 8 2008 355
4. J. Qiu, P.I. Terasaki, and K. Waki HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients Transplantation 81 2006 1658
5. M.S. Kumar, D.R. Sierka, and A.M. Damask Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients Kidney Int 67 2005 1622
6. S.A. Gruber, M.D. Doshi, and E. Cincotta Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates Transplantation 86 2008 269
7. J.M. Miro, J. Torre-Cisnero, and A. Moreno GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005) Enferm Infecc Microbiol Clin 23 2005 353
8. J.M. Poirier, P. Robidou, and P. Jaillon Quantification of the HIV-integrase inhibitor raltegravir (MK-0518) in human plasma by high-perfomance liquid chromatography with fluorescence detection J Chromatography B Analyt Technol Biomed Life Sci 867 2008 277
9. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31
10. J. Ayats-Ardite, J.M. Cisneros-Herreros, and J.L. Perez-Saenz Infectious disease assessment in solid organ transplant candidates Enferm Infecc Microbiol Clin 20 2002 448
11. C. Toso, T. Berney, and J. Oberholzer Kidney-pancreas transplantation in a long-term non-progressor HIV-infected recipient Am J Transplant 3 2003 631
12. N.J. Mller, H. Furrer, and L. Kaiser HIV and solid organ transplantation: the Swiss experience Swiss Med Wkly 136 2006 194
13. Grossi PA, Donati D, Gasperina DD,, et al. Kidney, Kidney- Pancreas and Liver-Kidney Transplantation in HIV Infected Individuals: The Italian Experience. Presented at the 8th American Transplant Congress Conference. June 2008, Toronto, Canada. Abstract number 1594
14. Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents Department of Health and Human Services November 3, 2008; p 1 www.AIDSinfo.nih.gov Accessed July 18, 2009
15. Expert Panel from Gesida and National AIDS Plan Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009) Enferm Infecc Microbiol Clin 27 2009 222
16. W. Towner, D. Klein, and H.L. Kerrigan Virologic outcomes of changing enfuvirtide to raltegravir in HIV-1 patients well controlled on an enfuvirtide based regimen: 24-week results of the CHEER study J Acquir Immune Defic Syndr 51 2009 367
17. L.A. Frassetto, M. Browne, and A. Cheng Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients Am J Transplant 7 2007 2816
18. Barrail-Tran A, Furlan V, Blouin P,, et al. Effect of coadministered boosted protease inhibitors regimen on tacrolimus blood concentration in 3 kidney transplanted HIV-infected patients [abstract 58]. 8th International Workshop on Clinical Pharmacology of HIV Therapy. Budapest, Hungary, April 1618, 2007
19. Teicher E, Vittecoq D, Taubert AM,, et al. Liver transplantation in HIV-coinfected patients treated with enfuvirtide. 13th Conference on Retroviruses and Opportunistic Infections. Denver, CO, USA. February 58, 2006; Abstract 874
20. C. Hicks, and R.M. Gulick Raltegravir: the first HIV type 1 integrase inhibitor Clin Infect Dis 48 2009 931
21. A. Moreno, R. Brcena, and C. Quereda Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation AIDS 22 2008 547
22. L. Tricot, E. Teicher, and G. Peytavin Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs Am J Transplant 9 2009 1
23. M. Iwamoto, L.A. Wenning, and B.Y. Nguyen Effects of omeprazole on plasma levels of raltegravir Clin Infect Dis 48 2009 489